04Mar
Global Private Equity Newsletter - Winter 2020 Edition: Deals in the Life Sciences Sector Article 1: Value Drivers and Risks
As the private equity industry matures, and the deal landscape becomes more competitive, private equity sponsors are becoming more prepared and capable of investing in sectors previously considered overly-regulated, requiring advanced chemistry or...
By:
Dechert LLP
Related
In Florida, when the injured employee’s attorney files a verified motion for attorney’s fees and c...
Read More >
U.S. and Chinese trade negotiators are “laying the groundwork for a delay of a fresh round of tarif...
Read More >
On May 20, 2020, the U.S. Senate passed S.945, the Holding Foreign Companies Accountable Act (“Bill...
Read More >
Last week, President Trump made headlines when he tweeted that “‘progressive’ Democrat Congresswo...
Read More >
On November 14, 2019 the Trump Administration proposed increasing the cost of filing many types of n...
Read More >
McDonald’s Corporation (“McDonald’s”) is facing two high-profile lawsuits involving allegations ...
Read More >